• M.Sc. or equivalent degree in a biological field (preferably: microbiology, molecular biology, biotechnology)
• Demonstrable laboratory experience and interest in learning new methods and techniques including work with S2 bacteria
• Good verbal and written communication skills in English
• Critical thinking and teamwork capabilities are highly valued

The newly established research group led by Dr. Stephan Spahn investigates how the intratumoral microbiome—cancer's "second genome"—interacts with precision medicine approaches in cholangiocarcinoma (CCA). Based at the newly-established M3 Research Center at the University of Tübingen, we study the complex relationships between intratumoral bacteria, bacteria-derived metabolites, and cancer hallmarks. Our mission is to translate fundamental discoveries into clinical applications that overcome therapy resistance in aggressive cancers like CCA.

This position offers the opportunity to contribute to innovative research at the intersection of microbiology, oncology, and precision medicine in an internationally recognized research environment.